A shrill beep pierced the sterile quiet of Leo’s hospital room. Clara’s head snapped up from the book she wasn't truly reading. Nurse Emily’s face, usually calm, creased with worry as she checked the monitor. “His oxygen levels are dipping again,” Emily murmured, her voice tight with concern. “And his heart rate is… fluctuating.” Clara’s stomach clenched. A cold dread seeped into her bones. Leo looked so small, so fragile, hooked up to the machines that kept him alive. Moments later, Dr. Rodriguez swept in, his expression grim. “We need to adjust his medication. The current dosage isn't holding him steady.” “Adjust it?” Clara whispered, her voice barely audible. “What’s wrong?” “We’re having trouble sourcing the next batch of the specialized serum,” Dr. Rodriguez admitted, his gaze flicking to Emily. “There’s been an… unexpected delay with the primary supplier.” Clara felt a sickening lurch. *Unexpected delay*. That phrase echoed with the same hollow ring as the postponed investor meeting. Marcus. It had to be him. “But Leo needs it,” she insisted, her voice gaining strength, bordering on desperation. “He can’t wait.” Emily nodded, her lips pressed into a thin line. “We’ve contacted every other pharmaceutical company we can. They either don’t have it or can’t get it to us in time.” Suddenly, the room felt like a cage. The air grew thick, suffocating. Leo’s shallow breaths seemed to mock her helplessness. This wasn't just about Thorne’s company anymore; it was about her son’s life. Grabbing her phone, Clara’s fingers flew across the screen. Thorne was the only one with enough power, enough reach, to untangle whatever web Marcus had woven. His voice, when he finally answered, was clipped, strained. “Clara? What is it?” “It’s Leo,” she choked out, fighting to keep her voice steady. “His medication. They can’t get it. They said there’s a delay with the supplier. It’s because of Marcus, isn’t it?” A beat of silence stretched, heavy and tense. Then, Thorne’s controlled exhale. “I’m on my way.” She hung up, her knuckles white. Minutes later, Thorne strode into the room, his eyes immediately locking onto Leo, then to Clara. His jaw was tight, a muscle twitching in his temple. The usual controlled power in his stance was overshadowed by a barely contained fury. “What exactly did Dr. Rodriguez say?” he asked, his voice low, a dangerous rumble beneath the surface. Clara relayed the information, her words tumbling out in a frantic rush. Thorne listened, his gaze unblinking. He pulled out his own phone, already dialing, his expression hardening with each unanswered call. “Vance,” he bit out, his voice sharp, when someone finally picked up. “What’s happening with the Med-Tech order for St. Jude’s?” She watched him pace, his frustration mounting with every passing minute. He slammed his fist softly against the wall when a contact told him they couldn’t bypass the new ‘compliance protocols’ that had suddenly appeared. “Marcus has found a way to freeze our supply chain,” Thorne explained, running a hand through his hair, his eyes blazing with a fierce determination. “He’s using newly implemented, overly strict regulations to halt shipments, citing potential ‘quality control’ issues. It’s a complete fabrication, but it’s effective.” “But why Leo’s medication?” Clara asked, her heart sinking even lower. “What could he possibly gain?” “He doesn’t care about Leo,” Thorne stated, his voice flat with disgust. “He cares about hurting me. Leo’s treatment is just collateral damage in his war against my company. He wants to show my investors I’m distracted, that my personal life is compromising my judgment and my ability to secure critical resources.” Clara felt a fresh wave of nausea. He was right. Marcus didn’t see Leo as a child; he saw him as a weakness, a lever to exploit. “We have to do something,” she urged, her eyes pleading. “There has to be another way.” Thorne stopped pacing, his gaze meeting hers. A flicker of raw vulnerability crossed his features before being quickly masked. “There might be. There’s a smaller, independent lab in Zurich. They developed a similar compound a few years ago. It’s experimental, but it might work.” “Zurich?” Clara’s brow furrowed. “How do we even get it here in time?” “Private jet,” Thorne said immediately, already pulling up contacts. “But it’s a long shot. They rarely release their compounds to external hospitals without extensive trials.” “Then we convince them,” Clara said, her voice firm. “We give them everything they need, every medical record, every guarantee. Whatever it takes.” They moved to the small waiting area outside Leo’s room, a flurry of urgent activity. Thorne barked orders into his phone, his deep voice resonating with authority, even under duress. Clara, meanwhile, pulled up Leo’s extensive medical history on her tablet, cross-referencing studies, researching the Zurich lab’s protocols. Minutes stretched into an agonizing hour. Thorne’s calls grew more desperate. The Zurich lab was hesitant, citing protocol, liability, the usual bureaucratic hurdles. Leo’s condition remained critical, a stark reminder of the ticking clock. “They’re saying no,” Thorne finally muttered, running a hand over his face. The strain was evident, lines etched around his eyes. “They won’t budge without direct approval from their chief medical officer, who is currently at a conference in Singapore.” Singapore. The word hung in the air, a cruel, impossible distance. “No,” Clara said, shaking her head. “We can’t accept that. There has to be someone else. A board member? An influential donor?” She started typing furiously on her tablet, cross-referencing the Zurich lab’s board of directors with philanthropic organizations. Her eyes scanned names, looking for any connection, any leverage. “Wait,” she breathed, her finger tracing a name on the screen. “Dr. Anya Sharma. She sits on their board, and she’s a huge proponent of pediatric rare disease research. I remember reading an article about her initiatives for expedited access to experimental treatments.” Thorne leaned over, his gaze intense as he read the name. “Sharma. I know her. We met at a medical technology summit. She’s formidable.” “Can you reach her?” Clara asked, her eyes wide with a fragile hope. “Explain Leo’s case?” “I’ll try,” Thorne said, already searching his contacts. He found her number, his thumb hovering over the call button. He shot Clara a look, a silent plea for luck. He spoke rapidly, concisely, explaining Leo’s dire situation, the specific compound, the critical need. Clara listened, her heart hammering against her ribs, watching Thorne’s face for any sign of progress. He was making promises, offering resources, anything to sway Dr. Sharma. Finally, he hung up. His shoulders slumped slightly, then straightened. “She’s considering it. She wants a full report, a video conference with Dr. Rodriguez, and a guarantee of absolute discretion regarding the compound’s origins.” “We can do that!” Clara exclaimed, relief washing over her, almost knocking her off her feet. “Right now!” They worked in a frantic, synchronized dance. Thorne coordinated the video call with Dr. Rodriguez, providing secure lines. Clara compiled the detailed patient report, highlighting Leo’s specific genetic markers and treatment history. Their fingers flew across keyboards, eyes darting between screens, a shared desperation fueling their actions. “I need you to confirm these dosage calculations,” Clara said, pushing her tablet towards Thorne. “My mind is racing.” He took the tablet, his fingers brushing hers as he accepted the device. A jolt, sharp and unexpected, arced between them. Their eyes met, wide and startled, in the chaotic energy of the moment. The world seemed to pause, suspended in that brief, electric contact, before the urgency of Leo’s crisis pulled them back. The spark, though fleeting, had been undeniable.

Crisis Unites Them